Topic

Vitrakvi (larotrectinib)

A collection of 28 issues

Getting Vitrakvi (Larotrectinib) Covered by Humana in Ohio: Complete Coding, PA, and Appeals Guide

Answer Box: Your Fastest Path to Vitrakvi Coverage Getting Vitrakvi (larotrectinib) covered by Humana in Ohio requires proper NTRK gene fusion documentation, correct ICD-10 coding, and meeting prior authorization requirements. Most approvals happen within 1-2 business days when submitted electronically with complete documentation. Your 3-step action plan: 1. Confirm NTRK

How Long Does It Take to Get Vitrakvi (larotrectinib) Approved by Aetna CVS Health in Florida? Complete Timeline & Appeal Guide

Answer Box: Getting Vitrakvi Approved by Aetna CVS Health in Florida Aetna CVS Health requires prior authorization for Vitrakvi (larotrectinib) with a standard 72-hour decision timeline (24 hours for urgent cases). Success depends on complete documentation: validated NTRK gene fusion test results, oncologist prescription, proof of metastatic/unresectable disease, and

Do You Qualify for Vitrakvi (Larotrectinib) Coverage by Humana in New Jersey? Decision Tree & Next Steps

Answer Box: Getting Vitrakvi Covered by Humana in New Jersey Yes, you can get Vitrakvi (larotrectinib) covered by Humana if you have a confirmed NTRK gene fusion-positive solid tumor and meet medical necessity criteria. Fastest path: Your oncologist submits prior authorization through Humana's provider portal with NTRK fusion

Renewing Vitrakvi (Larotrectinib) Approval with Humana in Washington: Timeline, Documentation & Appeals Guide

Answer Box: Renewing Vitrakvi Coverage with Humana in Washington Vitrakvi (larotrectinib) requires prior authorization renewal with Humana every 3-6 months. Start your renewal 30-45 days before expiration. Submit: updated clinical notes showing continued benefit, recent imaging demonstrating response/stable disease, current liver function tests, and NTRK fusion documentation. If denied,

Getting Vitrakvi (Larotrectinib) Covered by Cigna in New Jersey: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Vitrakvi (Larotrectinib) Covered by Cigna in New Jersey Eligibility: Cigna requires prior authorization for Vitrakvi (larotrectinib) with documented NTRK gene fusion, unresectable/metastatic solid tumors, and oncologist prescribing. Fastest path: Submit PA request via CoverMyMeds portal with NTRK fusion test results, prior therapy documentation, and medical necessity

How to Get Vitrakvi (Larotrectinib) Covered by Aetna CVS Health in Texas: Complete Coverage and Appeal Guide

Answer Box: Getting Vitrakvi Covered by Aetna CVS Health in Texas Vitrakvi (larotrectinib) requires prior authorization with Aetna CVS Health in Texas and documentation of a positive NTRK gene fusion test. The fastest path to approval: (1) Ensure your oncologist has your NTRK fusion test results ready, (2) Submit the

How to Get Vitrakvi (Larotrectinib) Covered by UnitedHealthcare in Florida: 2025 PA Requirements and Appeal Guide

Quick Answer: Getting Vitrakvi Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Vitrakvi (larotrectinib) in Florida. To get approved: (1) Submit a PA request through OptumRx with confirmed NTRK gene fusion testing results, (2) document that your solid tumor is metastatic/unresectable with no satisfactory alternatives, and (3)

How to Get Vitrakvi (Larotrectinib) Covered by UnitedHealthcare in Texas: Complete Forms, Appeals & Contact Guide

Answer Box: Getting Vitrakvi Covered in Texas UnitedHealthcare requires prior authorization for Vitrakvi (larotrectinib) in Texas. For patients under 19, approval requires only age verification. Adults need documented NTRK gene fusion, metastatic/unresectable tumor, and no satisfactory alternatives. Submit the UnitedHealthcare PA form with molecular testing results through the provider